Tocilizumab 8 mg/kg + MTX/DMARD vs placebo + DMARDs/biologic
ACR50% improvement criteria · patients with rheumatoid arthritis
Tocilizumab 8 mg/kg + MTX/DMARD leads to higher ACR50% improvement criteria compared with placebo + MTX/DMARD (high certainty).
1 finding from 1 review
- RR 3.17 [2.72, 3.67]4 studies · 2063 participantsHigh